Emiliano Cappello
Florence, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
SodiuM glucose cotrANsporter-2 (SGLT-2) inhibitors in the treatment of type II DiAbetes in Tuscany: utiLizatiOn patteRns, and relatEd clinical use evaluation; the MANDALORE study protocol.
Journal: Frontiers in endocrinology
Published: November 06, 2025
Possible underdiagnosis of ulcerative colitis in tertiary care can affect medication use and access to healthcare facilities.
Journal: Frontiers in immunology
Published: August 27, 2025
Signals of Possibly Persistent Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Disproportionality Analysis Using the EudraVigilance Database.
Journal: Drug safety
Published: October 17, 2024
Cohort event monitoring of safety of COVID-19 vaccines: the Italian experience of the "ilmiovaccinoCOVID19 collaborating group".
Journal: Frontiers in drug safety and regulation
Published: December 29, 2023
Prevalence, Incidence, and Mortality of Myasthenia Gravis and Myasthenic Syndromes: A Systematic Review.
Journal: Neuroepidemiology
Published: November 15, 2023
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option.
Journal: Expert opinion on drug discovery
Published: October 13, 2023
Potential missed diagnoses of Crohn's disease in tertiary care: impact on drug utilization and healthcare facilities use.
Journal: European journal of gastroenterology & hepatology
Published: September 19, 2023
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy.
Journal: Frontiers in pharmacology
Published: June 22, 2023
Comment on: "Deliberate Self-Poisoning: Real-Time Characterisation of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System".
Journal: Drug safety
Published: June 18, 2023
Signal management and risk minimization strategy: a case study on obinutuzumab and non-overt disseminated intravascular coagulation.
Journal: Frontiers in drug safety and regulation
Published: March 27, 2023
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 23, 2023
Last Updated: 09/26/2026